Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma

Author:

Datta Debanjali12,Dasgupta Archya12ORCID,Chatterjee Abhishek12,Sahu Arpita23ORCID,Bhattacharya Kajari23,Meena Lilawati24,Joshi Kishore24,Puranik Ameya25ORCID,Dev Indraja25,Moiyadi Aliasgar26ORCID,Shetty Prakash26,Singh Vikas26,Patil Vijay27,Menon Nandini27,Sridhar Sridhar28,Sahay Ayushi28,Gupta Tejpal12

Affiliation:

1. Department of Radiation Oncology, Tata Memorial Centre, Mumbai 400012, India

2. Homi Bhabha National Institute (HBNI), Mumbai 400012, India

3. Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai 400012, India

4. Department of Medical Physics, Tata Memorial Centre, Mumbai 400012, India

5. Department of Nuclear Medicine, Tata Memorial Centre, Mumbai 400012, India

6. Department of Neurosurgery, Tata Memorial Centre, Mumbai 400012, India

7. Department of Medical Oncology, Tata Memorial Centre, Mumbai 400012, India

8. Department of Pathology, Tata Memorial Centre, Mumbai 400012, India

Abstract

Background: Re-irradiation (ReRT) is an effective treatment modality in appropriately selected patients with recurrent/progressive high-grade glioma (HGG). The literature is limited regarding recurrence patterns following ReRT, which was investigated in the current study. Methods: Patients with available radiation (RT) contours, dosimetry, and imaging-based evidence of recurrence were included in the retrospective study. All patients were treated with fractionated focal conformal RT. Recurrence was detected on imaging with magnetic resonance imaging (MRI) and/ or amino-acid positron emission tomography (PET), which was co-registered with the RT planning dataset. Failure patterns were classified as central, marginal, and distant if >80%, 20–80%, or <20% of the recurrence volumes were within 95% isodose lines, respectively. Results: Thirty-seven patients were included in the current analysis. A total of 92% of patients had undergone surgery before ReRT, and 84% received chemotherapy. The median time to recurrence was 9 months. Central, marginal, and distant failures were seen in 27 (73%), 4 (11%), and 6 (16%) patients, respectively. None of the patient-, disease-, or treatment-related factors were significantly different across different recurrence patterns. Conclusion: Failures are seen predominantly within the high-dose region following ReRT in recurrent/ progressive HGG.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3